Corrigendum: Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway. The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.